ICUCW — SeaStar Medical Holding Corp

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1831868 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 495,000 449,000 -3,603,000 -3,521,000 11,263,000 9,348,000 3,948,000
Dec 2025 420,000 408,000 -3,016,000 -2,904,000 14,158,000 11,980,000 3,742,000
Sep 2025 183,000 169,000 -3,579,000 -3,472,000 15,530,000 13,763,000 4,066,000
Jun 2025 338,000 311,000 -1,756,000 -2,002,000 8,383,000 6,302,000 5,042,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-13,706,000
Investing CF
Financing CF
$17,758,000
CapEx
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-155,235,000
Inventory
$57,000
Receivables
$179,000
ST Investments
EBIT TTM
$-11,868,000
Pretax Income TTM
$-11,896,000
Interest Exp TTM
$28,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,713,000
EBITDA
Free Cash Flow
$-9,141,000
Enterprise Value
Total Cash
$6,959,000
Total Debt
$134,000
Shares Out
Trailing EPS
Book Value
$1.01
ROE
-356.9%
ROA
-102.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,234,000 -12,175,000 -12,150,000 14,158,000 3,742,000 -13,599,000
Dec 2024 135,000 -17,842,000 -24,830,000 4,658,000 6,841,000 -16,007,000
Dec 2023 0 -14,210,000 -26,232,000 3,513,000 17,383,000 -10,285,000
Dec 2022 0 -11,609,000 -12,190,000 3,038,000 23,800,000 -7,794,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-12,697,000
OpCashFlow TTM
$0
Assets (Latest)
$4,658,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $133.84B $373.57
SYK STRYKER CORP $125.74B $327.81
MDT Medtronic plc $118.91B $92.90
MMM 3M CO $92.32B $179.01
BSX BOSTON SCIENTIFIC CORP $71.03B $49.01

News headlines (Yahoo Finance, 1h cache)

ICU: Continued Revenue Growth for QUELIMMUNE®
2026-08-17 13:12 · Yahoo
SeaStar Medical Holding Corp (ICU) (Q2 2026) Earnings Call Highlights: Qualimmune Revenue ...
2026-08-13 05:02 · Yahoo
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript
2026-08-13 01:43 · Yahoo
SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-08-12 20:05 · Yahoo
SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026
2026-08-06 12:35 · Yahoo
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
2026-07-14 12:34 · Yahoo
Q2 Virtual Investor Summit Presentations Now Available On Demand
2026-06-30 17:20 · Yahoo
Q2 Investor Summit Virtual Live Wednesday June 24
2026-06-23 19:40 · Yahoo
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
2026-06-23 12:25 · Yahoo
SeaStar Medical to Present at Upcoming Investor Summit Conference
2026-06-22 12:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.